Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Re (RMAX) EBT (2016 - 2025)

Re (RMAX) has disclosed EBT for 14 consecutive years, with $1.6 million as the latest value for Q4 2025.

  • On a quarterly basis, EBT rose 136.77% to $1.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $15.3 million, a 233.4% increase, with the full-year FY2025 number at $45.4 million, up 221.96% from a year prior.
  • EBT was $1.6 million for Q4 2025 at Re, down from $10.3 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $59.8 million in Q4 2021 to a low of -$41.6 million in Q3 2021.
  • A 5-year average of $1.2 million and a median of $1.6 million in 2021 define the central range for EBT.
  • Peak YoY movement for EBT: skyrocketed 736.74% in 2021, then crashed 5768.83% in 2023.
  • Re's EBT stood at $59.8 million in 2021, then tumbled by 98.37% to $975000.0 in 2022, then tumbled by 2055.28% to -$19.1 million in 2023, then skyrocketed by 77.49% to -$4.3 million in 2024, then surged by 136.77% to $1.6 million in 2025.
  • Per Business Quant, the three most recent readings for RMAX's EBT are $1.6 million (Q4 2025), $10.3 million (Q3 2025), and $6.1 million (Q2 2025).